Developer of Minimally Invasive Cardiovascular Treatment Devices
On July 5, Yimai Yangguang Imaging Hospital Group (hereinafter referred to as “Yimai Yangguang”) completed the signing with the lead investor of its Series C financing round and the initial closing.
This funding round was led by PICC Equity Investment. The remaining investors and investment amounts in this series of financing will be announced sequentially upon completion of the investment. CICC, Huajing Securities, and Guojin Securities, three long-term capital market partners, provided financial services for this round of financing. It is understood that, to date, this is the largest single investment received by an independent third-party startup in the medical field in China.
Yimai Yangguang, founded in Shenzhen in October 2014, is the pioneer of the non-public medical business model for medical imaging in China. After more than four years of investment development and steady operation, Yimai Yangguang now operates nearly 80 offline medical imaging centers, has built the “Yimai Cloud” platform with a cumulative archive of tens of millions of imaging records, and established the Medical Imaging Academy, which has trained over 1,000 imaging physicians, technologists, and nursing staff. The financing secured in this round will be continuously invested into the deep integration of key elements, including the operation of medical imaging centers, talent development, and technological R&D.
It is understood that following its Series C financing, Yimai Yangguang will not only continue its selective expansion in high-quality markets but also concentrate greater human, financial, and other resources on refining operations at its existing nearly 80 imaging centers. The company will intensify talent development efforts by implementing diverse management and professional skills training programs tailored for imaging center directors, radiologist teams, operational teams, technologist teams, and nursing teams. Meanwhile, it will strengthen quality control management to establish standardized systems for image acquisition and diagnostic data within Yimai Yangguang, thereby laying a solid foundation for the accumulation of imaging big data and its integration with artificial intelligence, as well as for the convergence of medical services and data services.
Furthermore, following the completion of this financing round with PICC, Yimai Yangguang will engage in in-depth discussions with PICC on integrating imaging big data with health management and insurance services. The two parties aim to design health management products that are highly dependent on medical imaging examinations (such as health management for high-risk populations with cardiovascular and cerebrovascular diseases) and integrate them with insurance services. This collaboration will effectively combine Yimai Yangguang’s strengths in the field of medical imaging with PICC’s advantages in the insurance sector, creating a powerful synergy where both parties leverage each other’s capabilities to achieve mutual enhancement.
Some content has been omitted.
*Disclaimer: This article was written by an author contributing to Sina Medical News. The views expressed are solely those of the author and do not represent the position of Sina Medical News.